Your browser doesn't support javascript.
loading
[A multicenter clinical study for the comparison of S-1 versus capecitabine in the treatment of advanced breast cancer].
Li, Y; Jiang, D; Wu, Y Y; Li, L L; Cui, Y Z; Dong, Q.
Affiliation
  • Li Y; Department of Oncology, Fourth Hospital of Heibei Medical University, Shijiazhuang 050011, China.
  • Jiang D; Department of Oncology, Fourth Hospital of Heibei Medical University, Shijiazhuang 050011, China.
  • Wu YY; Department of Oncology, Fourth Hospital of Heibei Medical University, Shijiazhuang 050011, China.
  • Li LL; Department of Oncology, Fourth Hospital of Heibei Medical University, Shijiazhuang 050011, China.
  • Cui YZ; Department of Oncology, Fourth Hospital of Heibei Medical University, Shijiazhuang 050011, China.
  • Dong Q; Department of Oncology, Fourth Hospital of Heibei Medical University, Shijiazhuang 050011, China.
Zhonghua Zhong Liu Za Zhi ; 39(8): 607-612, 2017 Aug 23.
Article in Zh | MEDLINE | ID: mdl-28835084
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Breast Neoplasms / Tegafur / Capecitabine / Antimetabolites, Antineoplastic Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Female / Humans Language: Zh Journal: Zhonghua Zhong Liu Za Zhi Year: 2017 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Breast Neoplasms / Tegafur / Capecitabine / Antimetabolites, Antineoplastic Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Female / Humans Language: Zh Journal: Zhonghua Zhong Liu Za Zhi Year: 2017 Document type: Article Affiliation country: China Country of publication: China